Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H14N2O |
Molecular Weight | 190.2417 |
Optical Activity | ( - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CNC[C@@]([H])(C1)C3=CC=CC(=O)N3C2
InChI
InChIKey=ANJTVLIZGCUXLD-DTWKUNHWSA-N
InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1
Molecular Formula | C11H14N2O |
Molecular Weight | 190.2417 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:40:34 UTC 2023
by
admin
on
Fri Dec 15 19:40:34 UTC 2023
|
Record UNII |
53S5U404NU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N07BA04
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
207-616-0
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
11015
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
1723152
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
C004712
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
CYTISINE
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
5217
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
10235
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
3560
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
C166810
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
m4056
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000115739
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
53S5U404NU
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
SUB31171
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
DB09028
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
4055
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
FG-48
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
53S5U404NU
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
485-35-8
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
407282
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY | |||
|
DTXSID00883395
Created by
admin on Fri Dec 15 19:40:34 UTC 2023 , Edited by admin on Fri Dec 15 19:40:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->PARTIAL AGONIST |
|
||
|
LABELED -> NON-LABELED |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|